Skip to main content
Top
Published in: Molecular and Cellular Pediatrics 1/2014

Open Access 01-12-2014 | Mini review

Matrix metalloproteinases and epileptogenesis

Author: Chrysanthy Ikonomidou

Published in: Molecular and Cellular Pediatrics | Issue 1/2014

Login to get access

Abstract

Matrix metalloproteinases are vital drivers of synaptic remodeling in health and disease. It is suggested that at early stages of epileptogenesis, inhibition of matrix metalloproteinases may help ameliorate cell death, aberrant network rewiring, and neuroinflammation and prevent development of epilepsy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Goldberg EM, Coulter DA: Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction. Nat Rev Neurosci 2013, 14: 337–349. 10.1038/nrn3482CrossRef Goldberg EM, Coulter DA: Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction. Nat Rev Neurosci 2013, 14: 337–349. 10.1038/nrn3482CrossRef
2.
go back to reference Soleman S, Filipov MA, Dityatev A, Fawcett JW: Targeting the neural extracellular matrix in neurological disorders. Neuroscience 2013, 253: 194–213. 10.1016/j.neuroscience.2013.08.050CrossRef Soleman S, Filipov MA, Dityatev A, Fawcett JW: Targeting the neural extracellular matrix in neurological disorders. Neuroscience 2013, 253: 194–213. 10.1016/j.neuroscience.2013.08.050CrossRef
3.
go back to reference Yong VW: Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci 2005, 6: 931–944. 10.1038/nrn1807CrossRef Yong VW: Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci 2005, 6: 931–944. 10.1038/nrn1807CrossRef
4.
go back to reference Rosenberg GA: Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 2009, 8: 205–216. 10.1016/S1474-4422(09)70016-XCrossRef Rosenberg GA: Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 2009, 8: 205–216. 10.1016/S1474-4422(09)70016-XCrossRef
5.
go back to reference Ethel IM, Ethel DW: Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J Neurosci Res 2007, 85: 2813–2823. 10.1002/jnr.21273CrossRef Ethel IM, Ethel DW: Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J Neurosci Res 2007, 85: 2813–2823. 10.1002/jnr.21273CrossRef
6.
go back to reference Huntley GW: Synaptic circuit remodeling by matrix metalloproteinases in health and disease. Nat Rev Neurosci 2012, 13: 743–754. 10.1038/nrn3320CrossRef Huntley GW: Synaptic circuit remodeling by matrix metalloproteinases in health and disease. Nat Rev Neurosci 2012, 13: 743–754. 10.1038/nrn3320CrossRef
7.
go back to reference Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, Smith JW, Liddington RC, Lipton SA: S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 2002, 297: 1186–1190. 10.1126/science.1073634CrossRef Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, Smith JW, Liddington RC, Lipton SA: S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 2002, 297: 1186–1190. 10.1126/science.1073634CrossRef
8.
go back to reference Wilczynski GM, Konopacki FA, Wilczek E, Lasiecka Z, Gorlewicz A, Michaluk P, Wawrzyniak M, Malinowska M, Okulski P, Kolodziej LR, Konopka W, Duniec K, Mioduszewska B, Nikolaev E, Walczak A, Owczarek D, Gorecki DC, Zuschratter W, Ottersen OP, Kaczmarek L: Important role of matrix metalloproteinase-9 in epileptogenesis. J Cell Biol 2008, 10180: 1021–1035. 10.1083/jcb.200708213CrossRef Wilczynski GM, Konopacki FA, Wilczek E, Lasiecka Z, Gorlewicz A, Michaluk P, Wawrzyniak M, Malinowska M, Okulski P, Kolodziej LR, Konopka W, Duniec K, Mioduszewska B, Nikolaev E, Walczak A, Owczarek D, Gorecki DC, Zuschratter W, Ottersen OP, Kaczmarek L: Important role of matrix metalloproteinase-9 in epileptogenesis. J Cell Biol 2008, 10180: 1021–1035. 10.1083/jcb.200708213CrossRef
9.
go back to reference Yan Y, Hill YW, Rosenberg GA: Multiple roles of metalloproteinases in neurological disorders. Prog Mol Biol 2011, 99: 241–263. Yan Y, Hill YW, Rosenberg GA: Multiple roles of metalloproteinases in neurological disorders. Prog Mol Biol 2011, 99: 241–263.
10.
go back to reference Rosenberg GA: Neurological diseases in relation to the blood-brain barrier. J Cereb Blood Flow Metab 2012, 32: 1139–1151. 10.1038/jcbfm.2011.197CrossRef Rosenberg GA: Neurological diseases in relation to the blood-brain barrier. J Cereb Blood Flow Metab 2012, 32: 1139–1151. 10.1038/jcbfm.2011.197CrossRef
11.
go back to reference Sifringer M, Stefovska V, Zentner I, Hansen B, Stepulak A, Knaute C, Marzahn J, Ikonomidou C: The role of matrix metalloproteinases in infant traumatic brain injury. Neurobiol Dis 2007, 25: 526–535. 10.1016/j.nbd.2006.10.019CrossRef Sifringer M, Stefovska V, Zentner I, Hansen B, Stepulak A, Knaute C, Marzahn J, Ikonomidou C: The role of matrix metalloproteinases in infant traumatic brain injury. Neurobiol Dis 2007, 25: 526–535. 10.1016/j.nbd.2006.10.019CrossRef
12.
go back to reference Hoehna Y, Uckermann O, Luksch H, Stefovska V, Marzahn J, Theil M, Gorkiewicz T, Gawlak M, Wilczynski GM, Kaczmarek L, Ikonomidou C: Matrix metalloproteinase 9 regulates cell death following pilocarpine-induced seizures in the developing brain. Neurobiol Dis 2012, 48: 339–347. 10.1016/j.nbd.2012.06.023CrossRef Hoehna Y, Uckermann O, Luksch H, Stefovska V, Marzahn J, Theil M, Gorkiewicz T, Gawlak M, Wilczynski GM, Kaczmarek L, Ikonomidou C: Matrix metalloproteinase 9 regulates cell death following pilocarpine-induced seizures in the developing brain. Neurobiol Dis 2012, 48: 339–347. 10.1016/j.nbd.2012.06.023CrossRef
13.
go back to reference Nagy V, Bozdagi O, Matynia A, Balcerzyk M, Okulski P, Dzwonek J, Costa RM, Silva AJ, Kaczmarek L, Huntley GW: Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J Neurosci 2006, 26: 1923–1934. 10.1523/JNEUROSCI.4359-05.2006CrossRef Nagy V, Bozdagi O, Matynia A, Balcerzyk M, Okulski P, Dzwonek J, Costa RM, Silva AJ, Kaczmarek L, Huntley GW: Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J Neurosci 2006, 26: 1923–1934. 10.1523/JNEUROSCI.4359-05.2006CrossRef
14.
go back to reference Okulski P, Jay TM, Jaworski J, Duniec K, Dzwonek J, Konopacki FA, Wilczynski GM, Sánchez-Capelo A, Mallet J, Kaczmarek L: TIMP-1 abolishes MMP-9-dependent long-lasting long-term potentiation in the prefrontal cortex. Biol Psychiatry 2007, 62: 359–362. 10.1016/j.biopsych.2006.09.012CrossRef Okulski P, Jay TM, Jaworski J, Duniec K, Dzwonek J, Konopacki FA, Wilczynski GM, Sánchez-Capelo A, Mallet J, Kaczmarek L: TIMP-1 abolishes MMP-9-dependent long-lasting long-term potentiation in the prefrontal cortex. Biol Psychiatry 2007, 62: 359–362. 10.1016/j.biopsych.2006.09.012CrossRef
15.
go back to reference Bozdagi O, Nagy V, Kwei KT, Huntley GW: In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity. J Neurophysiol 2007, 98: 334–344. 10.1152/jn.00202.2007CrossRef Bozdagi O, Nagy V, Kwei KT, Huntley GW: In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity. J Neurophysiol 2007, 98: 334–344. 10.1152/jn.00202.2007CrossRef
16.
go back to reference Tian L, Stefanidakis M, Ning L, Van Lint P, Nyman-Huttunen H, Libert C, Itohara S, Mishina M, Rauvala H, Gahmberg CG: Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage. J Cell Biol 2007, 178: 687–700. 10.1083/jcb.200612097CrossRef Tian L, Stefanidakis M, Ning L, Van Lint P, Nyman-Huttunen H, Libert C, Itohara S, Mishina M, Rauvala H, Gahmberg CG: Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage. J Cell Biol 2007, 178: 687–700. 10.1083/jcb.200612097CrossRef
17.
go back to reference Konopacki FA, Rylski M, Wilczek E, Amborska R, Detka D, Kaczmarek L, Wilczynski GM: Synaptic localization of seizure-induced matrix metalloproteinase-9 mRNA. Neuroscience 2007, 150: 31–39. 10.1016/j.neuroscience.2007.08.026CrossRef Konopacki FA, Rylski M, Wilczek E, Amborska R, Detka D, Kaczmarek L, Wilczynski GM: Synaptic localization of seizure-induced matrix metalloproteinase-9 mRNA. Neuroscience 2007, 150: 31–39. 10.1016/j.neuroscience.2007.08.026CrossRef
18.
go back to reference Papadia S, Hardingham GE: The dichotomy of NMDA receptor signaling. Neuroscientist 2007, 13: 572–579. 10.1177/1073858407305833CrossRef Papadia S, Hardingham GE: The dichotomy of NMDA receptor signaling. Neuroscientist 2007, 13: 572–579. 10.1177/1073858407305833CrossRef
19.
go back to reference Schoknecht K, Shalev H: Blood-brain barrier dysfunction in brain diseases: clinical experience. Epilepsia 2012, 6: 7–13. 10.1111/j.1528-1167.2012.03697.xCrossRef Schoknecht K, Shalev H: Blood-brain barrier dysfunction in brain diseases: clinical experience. Epilepsia 2012, 6: 7–13. 10.1111/j.1528-1167.2012.03697.xCrossRef
20.
go back to reference Suenaga N, Ichiyama T, Kubota M, Isumi H, Tohyama J, Furukawa S: Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures. J Neurol Sci 2008, 266: 126–130. 10.1016/j.jns.2007.09.011CrossRef Suenaga N, Ichiyama T, Kubota M, Isumi H, Tohyama J, Furukawa S: Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures. J Neurol Sci 2008, 266: 126–130. 10.1016/j.jns.2007.09.011CrossRef
21.
go back to reference Mizoguchi H, Yamada K: Roles of matrix metalloproteinases and their targets in epileptogenesis and seizures. Clin Psychopharmacol Neurosci 2013, 11: 45–52. 10.9758/cpn.2013.11.2.45CrossRef Mizoguchi H, Yamada K: Roles of matrix metalloproteinases and their targets in epileptogenesis and seizures. Clin Psychopharmacol Neurosci 2013, 11: 45–52. 10.9758/cpn.2013.11.2.45CrossRef
22.
go back to reference Deng X, He G, Liu J, Luo F, Peng X, Tang S, Gao Z, Lin Q, Keller JM, Yang T, Keller ET: Recent advances in bone-targeted therapies of metastatic prostate cancer. Cancer Treat Rev 2014, 40: 730–738. 10.1016/j.ctrv.2014.04.003CrossRef Deng X, He G, Liu J, Luo F, Peng X, Tang S, Gao Z, Lin Q, Keller JM, Yang T, Keller ET: Recent advances in bone-targeted therapies of metastatic prostate cancer. Cancer Treat Rev 2014, 40: 730–738. 10.1016/j.ctrv.2014.04.003CrossRef
23.
go back to reference Stellas D, Patsavoudi E: Inhibiting matrix metalloproteinases, an old story with new potentials for cancer treatment. Anticancer Agents Med Chem 2012, 12: 707–717. 10.2174/187152012802650246CrossRef Stellas D, Patsavoudi E: Inhibiting matrix metalloproteinases, an old story with new potentials for cancer treatment. Anticancer Agents Med Chem 2012, 12: 707–717. 10.2174/187152012802650246CrossRef
Metadata
Title
Matrix metalloproteinases and epileptogenesis
Author
Chrysanthy Ikonomidou
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Molecular and Cellular Pediatrics / Issue 1/2014
Electronic ISSN: 2194-7791
DOI
https://doi.org/10.1186/s40348-014-0006-y

Other articles of this Issue 1/2014

Molecular and Cellular Pediatrics 1/2014 Go to the issue